Dayang Chem (Hangzhou) Co., Ltd.
China
Product Name: Cholesterol-3-18O
Price: $Inquiry/100g $Inquiry/1kg $Inquiry/100kg $Inquiry/1000kg
Purity: 98.0%
Stocking Period: Inquiry
Contact: Ms Wang

59613-51-3

59613-51-3 structure

Name: (3β)-Cholest-5-en-3-(18O)ol
Chemical Name: cholest-5-en-3β-[18O]ol
CAS Number: 59613-51-3
Molecular Formula: C₂₇H₄₆₁₈O
Molecular Weight: 388.65
Catalog: Signaling Pathways Others Estrogen Receptor/ERR
Create Date: 2016-09-22 07:46:25
Modify Date: 2024-01-05 21:27:08
Cholesterol-18O is the deuterium labeled Cholesterol. Cholesterol is the major sterol in mammals and is makes up 20-25% of structural component of the plasma membrane. Plasma membranes are highly permeable to water but relatively impermeable to ions and protons. Cholesterol plays an important role in determining the fluidity and permeability characteristics of the membrane as well as the function of both the transporters and signaling proteins[1][2]. Cholesterol is also an endogenous estrogen-related receptor α (ERRα) agonist[3][4].

Name	cholest-5-en-3β-[18O]ol
Synonyms	Cholesterol-3-18O Cholest-5-en-3-ol-O, (3β)- (3β)-Cholest-5-en-3-(O)ol CHOLESTEROL-18O

Description	Cholesterol-18O is the deuterium labeled Cholesterol. Cholesterol is the major sterol in mammals and is makes up 20-25% of structural component of the plasma membrane. Plasma membranes are highly permeable to water but relatively impermeable to ions and protons. Cholesterol plays an important role in determining the fluidity and permeability characteristics of the membrane as well as the function of both the transporters and signaling proteins[1][2]. Cholesterol is also an endogenous estrogen-related receptor α (ERRα) agonist[3][4].
Related Catalog	Signaling Pathways >> Others >> Estrogen Receptor/ERR
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Casaburi I, et al. Cholesterol as an Endogenous ERRα Agonist: A New Perspective to Cancer Treatment. Front Endocrinol (Lausanne). 2018 Sep 11;9:525. [3]. Dietschy JM, et al. Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res. 2004 Aug;45(8):1375-97. [4]. Fukui K, et al. Effect of Cholesterol Reduction on Receptor Signaling in Neurons. J Biol Chem. 2015 Sep 14.

Density	1.0±0.1 g/cm3
Molecular Formula	C₂₇H₄₆₁₈O
Molecular Weight	388.65
Exact Mass	388.359100
PSA	20.23000
LogP	7.38870
Index of Refraction	1.525

59613-51-3	604-32-0
604-35-3	8027-33-6
57-88-5	50305-81-2
51467-57-3	130167-69-0
42220-21-3	30948-01-7
1158522-08-7	940364-43-2
134104-43-1	131615-57-1
2741926-78-1	6906-52-1
930439-75-1	1018584-77-4
1375289-11-4	849349-65-1